vs

Side-by-side financial comparison of Duolingo, Inc. (DUOL) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Duolingo, Inc. is the larger business by last-quarter revenue ($295.5M vs $225.6M, roughly 1.3× Organogenesis Holdings Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 11.9%, a 7.5% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 27.0%). Duolingo, Inc. produced more free cash flow last quarter ($103.0M vs $34.8M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 28.7%).

Duolingo, Inc. is a leading global edtech firm operating a gamified language learning platform. It offers free and premium self-paced courses for over 40 languages, plus language certification, math learning tools, and literacy programs, serving individual learners, schools and corporate clients worldwide.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

DUOL vs ORGO — Head-to-Head

Bigger by revenue
DUOL
DUOL
1.3× larger
DUOL
$295.5M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+51.1% gap
ORGO
78.1%
27.0%
DUOL
Higher net margin
ORGO
ORGO
7.5% more per $
ORGO
19.4%
11.9%
DUOL
More free cash flow
DUOL
DUOL
$68.2M more FCF
DUOL
$103.0M
$34.8M
ORGO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
28.7%
DUOL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DUOL
DUOL
ORGO
ORGO
Revenue
$295.5M
$225.6M
Net Profit
$35.1M
$43.7M
Gross Margin
55.5%
Operating Margin
8.0%
28.1%
Net Margin
11.9%
19.4%
Revenue YoY
27.0%
78.1%
Net Profit YoY
24.0%
469.5%
EPS (diluted)
$0.72
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DUOL
DUOL
ORGO
ORGO
Q1 26
$295.5M
Q4 25
$282.9M
$225.6M
Q3 25
$271.7M
$150.9M
Q2 25
$252.3M
$101.0M
Q1 25
$230.7M
$86.7M
Q4 24
$209.6M
$126.7M
Q3 24
$192.6M
$115.2M
Q2 24
$178.3M
$130.2M
Net Profit
DUOL
DUOL
ORGO
ORGO
Q1 26
$35.1M
Q4 25
$42.0M
$43.7M
Q3 25
$292.2M
$21.6M
Q2 25
$44.8M
$-9.4M
Q1 25
$35.1M
$-18.8M
Q4 24
$13.9M
$7.7M
Q3 24
$23.4M
$12.3M
Q2 24
$24.4M
$-17.0M
Gross Margin
DUOL
DUOL
ORGO
ORGO
Q1 26
55.5%
Q4 25
72.8%
Q3 25
72.5%
Q2 25
72.4%
Q1 25
71.1%
72.6%
Q4 24
71.9%
75.5%
Q3 24
72.9%
76.7%
Q2 24
73.4%
77.6%
Operating Margin
DUOL
DUOL
ORGO
ORGO
Q1 26
8.0%
Q4 25
15.4%
28.1%
Q3 25
12.9%
13.7%
Q2 25
13.2%
-12.5%
Q1 25
10.2%
-30.9%
Q4 24
6.6%
8.1%
Q3 24
7.0%
5.4%
Q2 24
10.5%
-10.7%
Net Margin
DUOL
DUOL
ORGO
ORGO
Q1 26
11.9%
Q4 25
14.8%
19.4%
Q3 25
107.5%
14.3%
Q2 25
17.8%
-9.3%
Q1 25
15.2%
-21.7%
Q4 24
6.6%
6.1%
Q3 24
12.1%
10.7%
Q2 24
13.7%
-13.1%
EPS (diluted)
DUOL
DUOL
ORGO
ORGO
Q1 26
$0.72
Q4 25
$0.99
$0.31
Q3 25
$5.95
$0.11
Q2 25
$0.91
$-0.10
Q1 25
$0.72
$-0.17
Q4 24
$0.31
$0.05
Q3 24
$0.49
$0.09
Q2 24
$0.51
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DUOL
DUOL
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$1.1B
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
$300.1M
Total Assets
$2.0B
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DUOL
DUOL
ORGO
ORGO
Q1 26
$1.1B
Q4 25
$1.0B
$93.7M
Q3 25
$1.0B
$63.7M
Q2 25
$976.2M
$73.1M
Q1 25
$884.0M
$110.0M
Q4 24
$785.8M
$135.6M
Q3 24
$854.4M
$94.3M
Q2 24
$888.2M
$89.9M
Total Debt
DUOL
DUOL
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
DUOL
DUOL
ORGO
ORGO
Q1 26
$1.3B
Q4 25
$1.3B
$300.1M
Q3 25
$1.3B
$255.1M
Q2 25
$977.0M
$233.2M
Q1 25
$893.8M
$242.9M
Q4 24
$824.5M
$262.9M
Q3 24
$822.5M
$278.5M
Q2 24
$766.9M
$263.5M
Total Assets
DUOL
DUOL
ORGO
ORGO
Q1 26
$2.0B
Q4 25
$2.0B
$598.7M
Q3 25
$1.9B
$509.8M
Q2 25
$1.5B
$461.1M
Q1 25
$1.4B
$467.4M
Q4 24
$1.3B
$497.9M
Q3 24
$1.2B
$446.3M
Q2 24
$1.1B
$443.2M
Debt / Equity
DUOL
DUOL
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DUOL
DUOL
ORGO
ORGO
Operating Cash FlowLast quarter
$105.6M
$39.4M
Free Cash FlowOCF − Capex
$103.0M
$34.8M
FCF MarginFCF / Revenue
34.9%
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
3.01×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$368.4M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DUOL
DUOL
ORGO
ORGO
Q1 26
$105.6M
Q4 25
$107.3M
$39.4M
Q3 25
$84.2M
$3.1M
Q2 25
$90.7M
$-32.9M
Q1 25
$105.6M
$-19.9M
Q4 24
$83.3M
$10.9M
Q3 24
$56.3M
$8.7M
Q2 24
$62.4M
$4.7M
Free Cash Flow
DUOL
DUOL
ORGO
ORGO
Q1 26
$103.0M
Q4 25
$96.6M
$34.8M
Q3 25
$79.4M
$844.0K
Q2 25
$89.5M
$-36.5M
Q1 25
$104.3M
$-23.6M
Q4 24
$81.4M
$7.6M
Q3 24
$53.1M
$6.1M
Q2 24
$56.8M
$2.9M
FCF Margin
DUOL
DUOL
ORGO
ORGO
Q1 26
34.9%
Q4 25
34.1%
15.4%
Q3 25
29.2%
0.6%
Q2 25
35.5%
-36.1%
Q1 25
45.2%
-27.2%
Q4 24
38.8%
6.0%
Q3 24
27.6%
5.3%
Q2 24
31.9%
2.2%
Capex Intensity
DUOL
DUOL
ORGO
ORGO
Q1 26
Q4 25
3.8%
2.1%
Q3 25
1.8%
1.5%
Q2 25
0.5%
3.6%
Q1 25
0.6%
4.2%
Q4 24
0.9%
2.7%
Q3 24
1.7%
2.2%
Q2 24
3.1%
1.4%
Cash Conversion
DUOL
DUOL
ORGO
ORGO
Q1 26
3.01×
Q4 25
2.56×
0.90×
Q3 25
0.29×
0.14×
Q2 25
2.02×
Q1 25
3.01×
Q4 24
5.99×
1.43×
Q3 24
2.41×
0.71×
Q2 24
2.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DUOL
DUOL

Bookings$283.5M96%
Other$12.0M4%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons